Home
PODD
PODD News

Latest Insulet Corporation (PODD) News on April 19, 2025

4 Medical Product Stocks to Buy From a Challenging Industry

Zacks

2 days ago

4 Medical Product Stocks to Buy From a Challenging Industry

Argus Research

3 days ago

PODD: Raising target price to $282.00

MT Newswires

4 days ago

RBC Cuts Price Target on Insulet to $325 From $340, Keeps Outperform Rating

BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know

StockStory

9 days ago

BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know

Strength Seen in Insulet (PODD): Can Its 7.2% Jump Turn into More Strength?

Zacks

9 days ago

Strength Seen in Insulet (PODD): Can Its 7.2% Jump Turn into More Strength?

5 High-Flying Large-Cap Stocks to Buy Amid Tariff-Led Market Rout

Zacks

10 days ago

5 High-Flying Large-Cap Stocks to Buy Amid Tariff-Led Market Rout

Argus Research

10 days ago

PODD: Lowering target price to $272.00

PODD Stock Benefits From the Launch of Omnipod 5 in Canada

Zacks

11 days ago

PODD Stock Benefits From the Launch of Omnipod 5 in Canada

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

StockStory

11 days ago

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

This Insulin Pump Maker Expands Into New Territory And Its Stock Shows Relative Strength

Investor's Business Daily

12 days ago

This Insulin Pump Maker Expands Into New Territory And Its Stock Shows Relative Strength

Insulet (NasdaqGS:PODD) Launches Omnipod 5 In Canada As Shares Dip 7%

Simply Wall St.

12 days ago

Insulet (NasdaqGS:PODD) Launches Omnipod 5 In Canada As Shares Dip 7%

MT Newswires

12 days ago

Citigroup Adjusts Insulet Price Target to $315 From $355, Maintains Buy Rating

Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above

CNW Group

12 days ago

Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above

Morningstar Research

16 days ago

Analyst Report: Insulet Corporation

Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025

Business Wire

16 days ago

Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

StockStory

16 days ago

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

Argus Research

17 days ago

PODD: Lowering target price to $290.00

3 Reasons Investors Love Insulet (PODD)

StockStory

23 days ago

3 Reasons Investors Love Insulet (PODD)

MT Newswires

23 days ago

Insulet Insider Sold Shares Worth $501,875, According to a Recent SEC Filing

Argus Research

24 days ago

PODD: Rating increased to a BUY

Insulet Gains 62.9% in a Year: What's Driving the Stock?

Zacks

a month ago

Insulet Gains 62.9% in a Year: What's Driving the Stock?

Insulet (NasdaqGS:PODD) Completes US$450 Million Debt Financing; 7 Day Share Price Up 5%

Simply Wall St.

a month ago

Insulet (NasdaqGS:PODD) Completes US$450 Million Debt Financing; 7 Day Share Price Up 5%

PODD Stock Gains Following the Launch of Omnipod 5 in Australia

Zacks

a month ago

PODD Stock Gains Following the Launch of Omnipod 5 in Australia

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

StockStory

a month ago

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5

Zacks

a month ago

PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5

LendingTree and AMC Networks have been highlighted as Zacks Bull and Bear of the Day

Zacks

a month ago

LendingTree and AMC Networks have been highlighted as Zacks Bull and Bear of the Day

Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data

MedTech Dive

a month ago

Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data

MT Newswires

a month ago

Insulet Reports Glycemic Improvements With Omnipod Automated Insulin Delivery System

Insulet’s RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections

Business Wire

a month ago

Insulet’s RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections

3 Tariff-Proof Medical Device Stocks to Watch Amid Trump's MAGA Slogan

Zacks

a month ago

3 Tariff-Proof Medical Device Stocks to Watch Amid Trump's MAGA Slogan

MT Newswires

a month ago

Insulet Prices $450 Million Senior Notes Due 2033

Insulet Announces Pricing of Senior Notes Due 2033

Business Wire

a month ago

Insulet Announces Pricing of Senior Notes Due 2033

Insulet Corporation (PODD): Among the Best Diabetes Stocks to Buy According to Billionaires

Insider Monkey

a month ago

Insulet Corporation (PODD): Among the Best Diabetes Stocks to Buy According to Billionaires

Insulet Chief Technology Officer Mark Field leaves

MedTech Dive

a month ago

Insulet Chief Technology Officer Mark Field leaves

MT Newswires

a month ago

Insulet Plans $450 Million Senior Notes Offering

MT Newswires

a month ago

Insulet Launches Omnipod 5 Insulin Delivery System in Australia

Insulet Expands Omnipod® 5 to Four More International Markets

Business Wire

a month ago

Insulet Expands Omnipod® 5 to Four More International Markets

From Injections to Innovation – Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod® 5 in Adults and Children with Type 1 Diabetes

Business Wire

a month ago

From Injections to Innovation – Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod® 5 in Adults and Children with Type 1 Diabetes

Insulet (NasdaqGS:PODD) Declines 12% After Earnings Reveal Net Income Decrease

Simply Wall St.

a month ago

Insulet (NasdaqGS:PODD) Declines 12% After Earnings Reveal Net Income Decrease

Insulet to Host Investor Day on June 5, 2025

Business Wire

a month ago

Insulet to Host Investor Day on June 5, 2025

Insulet (NASDAQ:PODD) shareholders YoY returns are lagging the company's 15% five-year earnings growth

Simply Wall St.

a month ago

Insulet (NASDAQ:PODD) shareholders YoY returns are lagging the company's 15% five-year earnings growth

Robinhood initiated, MongoDB downgraded: Wall Street’s top analyst calls

TipRanks

a month ago

Robinhood initiated, MongoDB downgraded: Wall Street’s top analyst calls

MT Newswires

a month ago

RBC Initiates Insulet at Outperform With $340 Price Target

Argus Research

a month ago

PODD: Raising target price to $283.00

Morningstar Research

2 months ago

Analyst Report: Insulet Corporation

Tandem’s insulin pump tech wins FDA nod for Type 2 diabetes

MedTech Dive

2 months ago

Tandem’s insulin pump tech wins FDA nod for Type 2 diabetes

Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)

StockStory

2 months ago

Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)

Insulet Sales Keep Rising

FX Empire

2 months ago

Insulet Sales Keep Rising

Argus Research

2 months ago

PODD: Lowering target price to $280.00

Medtronic Stock Gets IBD Rating Lift

Investor's Business Daily

2 months ago

Medtronic Stock Gets IBD Rating Lift

MT Newswires

2 months ago

Redburn Atlantic Adjusts Price Target on Insulet to $315 From $300, Keeps Buy Rating

MT Newswires

2 months ago

Bernstein Adjusts Price Target on Insulet to $335 From $315, Keeps Outperform Rating

Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst

Benzinga

2 months ago

Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst

Morningstar Research

2 months ago

Analyst Report: Insulet Corporation

MT Newswires

2 months ago

Wells Fargo Adjusts Insulet Price Target to $322 From $305

MT Newswires

2 months ago

Citigroup Adjusts Insulet Price Target to $355 From $310

MT Newswires

2 months ago

Stifel Nicolaus Adjusts Insulet Price Target to $293 From $245

MT Newswires

2 months ago

BTIG Research Adjusts Insulet Price Target to $310 From $300

MT Newswires

2 months ago

Leerink Partners Adjusts Insulet Price Target to $314 From $278

MT Newswires

2 months ago

Piper Sandler Adjusts Insulet Price Target to $310 From $285

MT Newswires

2 months ago

Canaccord Genuity Adjusts Insulet Price Target to $324 From $304

MT Newswires

2 months ago

Wolfe Research Adjusts Insulet Price Target to $315 From $265

Insulet Earnings: What To Look For From PODD

StockStory

2 months ago

Insulet Earnings: What To Look For From PODD

Argus Research

2 months ago

PODD: Lowering target price to $295.00

Stay Ahead of the Game With Insulet (PODD) Q4 Earnings: Wall Street's Insights on Key Metrics

Zacks

2 months ago

Stay Ahead of the Game With Insulet (PODD) Q4 Earnings: Wall Street's Insights on Key Metrics

If EPS Growth Is Important To You, Insulet (NASDAQ:PODD) Presents An Opportunity

Simply Wall St.

2 months ago

If EPS Growth Is Important To You, Insulet (NASDAQ:PODD) Presents An Opportunity

Argus Research

2 months ago

PODD: Raising target price to $292.00

Zacks.com featured highlights NVIDIA, AppLovin and Insulet

Zacks

3 months ago

Zacks.com featured highlights NVIDIA, AppLovin and Insulet

NVIDIA & 2 Other Profitable Stocks to Buy in February

Zacks

3 months ago

NVIDIA & 2 Other Profitable Stocks to Buy in February

Here's Why You Should Add PODD Stock to Your Portfolio Now

Zacks

3 months ago

Here's Why You Should Add PODD Stock to Your Portfolio Now

Argus Research

3 months ago

PODD: What does Argus have to say about PODD?

Argus Research

3 months ago

PODD: Raising target price to $290.00

GEHC or PODD: Which Is the Better Value Stock Right Now?

Zacks

3 months ago

GEHC or PODD: Which Is the Better Value Stock Right Now?

Argus Research

3 months ago

PODD: Raising target price to $280.00

PODD Stock Gains From the Launch of Omnipod 5 in Five Countries in EU

Zacks

3 months ago

PODD Stock Gains From the Launch of Omnipod 5 in Five Countries in EU

MT Newswires

3 months ago

Insulet Begins Commercial Sales of Omnipod 5 Insulin Delivery System in 5 More Countries

Insulet Launches Revolutionary Omnipod® 5 in Five More Countries in Europe

Business Wire

3 months ago

Insulet Launches Revolutionary Omnipod® 5 in Five More Countries in Europe

Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

Business Wire

3 months ago

Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

MT Newswires

3 months ago

Bernstein Adjusts Price Target on Insulet to $315 From $305, Keeps Outperform Rating

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Zacks

3 months ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Insulin Device Maker Has Analysts Turning Bullish

Investor's Business Daily

3 months ago

Insulin Device Maker Has Analysts Turning Bullish

What Does Insulet Corporation's (NASDAQ:PODD) Share Price Indicate?

Simply Wall St.

3 months ago

What Does Insulet Corporation's (NASDAQ:PODD) Share Price Indicate?

MT Newswires

3 months ago

UBS Adjusts Price Target on Insulet to $280 From $253, Keeps Neutral Rating

MT Newswires

4 months ago

TD Cowen Adjusts Price Target on Insulet to $324 From $264, Keeps Buy Rating

GEHC vs. PODD: Which Stock Is the Better Value Option?

Zacks

4 months ago

GEHC vs. PODD: Which Stock Is the Better Value Option?

Insulet price target raised to $300 from $270 at BTIG

TipRanks

4 months ago

Insulet price target raised to $300 from $270 at BTIG

MT Newswires

4 months ago

BTIG Raises Price Target on Insulet to $300 From $270, Maintains Buy Rating

Heavy Interest in Insulet’s Insulin Delivery Device

FX Empire

4 months ago

Heavy Interest in Insulet’s Insulin Delivery Device

Argus Research

4 months ago

PODD: Lowering target price to $276.00

Insulet Corporation (NASDAQ:PODD) Delivered A Better ROE Than Its Industry

Simply Wall St.

4 months ago

Insulet Corporation (NASDAQ:PODD) Delivered A Better ROE Than Its Industry

MT Newswires

4 months ago

Baird Adjusts Insulet Price Target to $325 From $280, Maintains Outperform Rating

MT Newswires

4 months ago

Redburn Atlantic Raises Price Target on Insulet to $300 From $270, Keeps Buy Rating

Argus Research

4 months ago

PODD: Lowering target price to $277.00

Why Insulet (PODD) is a Top Momentum Stock for the Long-Term

Zacks

4 months ago

Why Insulet (PODD) is a Top Momentum Stock for the Long-Term

RMD or PODD: Which Is the Better Value Stock Right Now?

Zacks

4 months ago

RMD or PODD: Which Is the Better Value Stock Right Now?

MT Newswires

4 months ago

Nephron Research Adjusts Price Target on Insulet to $310 From $285

MT Newswires

4 months ago

JPMorgan Raises Insulet Price Target to $330 From $280, Maintains Overweight Rating

Inari Medical Stock Gets RS Rating Upgrade

Investor's Business Daily

4 months ago

Inari Medical Stock Gets RS Rating Upgrade

MT Newswires

4 months ago

Wells Fargo Adjusts Price Target on Insulet to $305 From $290, Keeps Overweight Rating

MT Newswires

4 months ago

Citigroup Raises Price Target on Insulet to $310 From $283, Keeps Buy Rating

Share on Social Networks: